These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 8838503)

  • 21. The role of cytokines in osteoarthritis pathophysiology.
    Fernandes JC; Martel-Pelletier J; Pelletier JP
    Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.
    Liu FL; Chen CH; Chu SJ; Chen JH; Lai JH; Sytwu HK; Chang DM
    Rheumatology (Oxford); 2007 Aug; 46(8):1266-73. PubMed ID: 17569750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of T-614 on tumor necrosis factor-alpha induced cytokine production and nuclear factor-kappaB activation in cultured human synovial cells.
    Kohno M; Aikawa Y; Tsubouchi Y; Hashiramoto A; Yamada R; Kawahito Y; Inoue K; Kusaka Y; Kondo M; Sano H
    J Rheumatol; 2001 Dec; 28(12):2591-6. PubMed ID: 11764202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of human normal and osteoarthritic chondrocyte interleukin-1 receptor by antirheumatic drugs.
    Pelletier JP; McCollum R; DiBattista J; Loose LD; Cloutier JM; Martel-Pelletier J
    Arthritis Rheum; 1993 Nov; 36(11):1517-27. PubMed ID: 8240429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.
    Butler DM; Maini RN; Feldmann M; Brennan FM
    Eur Cytokine Netw; 1995; 6(4):225-30. PubMed ID: 8789287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.
    Bramlage CP; Kaps C; Ungethüm U; Bramlage P; Koziolek M; Wessels J; Krenn V; Pruss A; Müller GA; Strutz F; Burmester GR; Häupl T
    Scand J Rheumatol; 2008; 37(6):401-9. PubMed ID: 18830904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts.
    Butler DM; Feldmann M; Di Padova F; Brennan FM
    Eur Cytokine Netw; 1994; 5(5):441-8. PubMed ID: 7880974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
    Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
    Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells.
    McNiff PA; Stewart C; Sullivan J; Showell HJ; Gabel CA
    Cytokine; 1995 Feb; 7(2):209-19. PubMed ID: 7780041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies.
    DeForge LE; Kenney JS; Jones ML; Warren JS; Remick DG
    J Immunol; 1992 Apr; 148(7):2133-41. PubMed ID: 1545121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes.
    Jang CH; Choi JH; Byun MS; Jue DM
    Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis.
    Kotake S; Schumacher HR; Yarboro CH; Arayssi TK; Pando JA; Kanik KS; Gourley MF; Klippel JH; Wilder RL
    Proc Assoc Am Physicians; 1997 May; 109(3):286-301. PubMed ID: 9154645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expression.
    Kunsch C; Luchoomun J; Chen XL; Dodd GL; Karu KS; Meng CQ; Marino EM; Olliff LK; Piper JD; Qiu FH; Sikorski JA; Somers PK; Suen KL; Thomas S; Whalen AM; Wasserman MA; Sundell CL
    J Pharmacol Exp Ther; 2005 May; 313(2):492-501. PubMed ID: 15701708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex-vivo in-vitro inhibition of lipopolysaccharide stimulated tumor necrosis factor-alpha and interleukin-1 beta secretion in human whole blood by extractum urticae dioicae foliorum.
    Obertreis B; Ruttkowski T; Teucher T; Behnke B; Schmitz H
    Arzneimittelforschung; 1996 Apr; 46(4):389-94. PubMed ID: 8740085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of tenidap on canine experimental osteoarthritis: II. Study of the expression of collagenase-1 and interleukin 1beta by in situ hybridization.
    Fernandes JC; Martel-Pelletier J; Jovanovic D; Tardif G; DiBattista JA; Lascau-Coman V; Otterness IG; Pelletier JP
    J Rheumatol; 1998 May; 25(5):951-8. PubMed ID: 9598897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
    Buchan G; Barrett K; Turner M; Chantry D; Maini RN; Feldmann M
    Clin Exp Immunol; 1988 Sep; 73(3):449-55. PubMed ID: 3264773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
    Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ
    J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells.
    Juarranz MG; Santiago B; Torroba M; Gutierrez-Cañas I; Palao G; Galindo M; Abad C; Martinez C; Leceta J; Pablos JL; Gomariz RP
    Rheumatology (Oxford); 2004 Apr; 43(4):416-22. PubMed ID: 14657510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.